Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.79
|
|
2.82
|
2.74
|
2.98
|
2.87
|
|
|
13 367.68
|
97.00
|
1.12
|
|
2.83
|
2.70
|
2.83
|
2.82
|
|
|
3 067.79
|
21.00
|
2.60
|
|
2.70
|
2.60
|
2.78
|
2.78
|
|
|
7 480.59
|
38.00
|
2.61
|
|
2.68
|
2.59
|
2.68
|
2.66
|
|
|
5 200.09
|
45.00
|
2.38
|
|
2.3801
|
2.3801
|
2.61
|
2.52
|
|
|
4 684.65
|
33.00
|
2.45
|
|
2.50
|
2.31
|
2.75
|
2.49
|
|
|
21 544.13
|
254.00
|
2.38
|
|
2.67
|
2.43
|
2.6899
|
2.56
|
|
|
17 926.87
|
163.00
|
|
|
2.67
|
2.39
|
2.76
|
2.58
|
|
|
60 855.13
|
275.00
|
|
|
2.77
|
2.50
|
2.90
|
2.70
|
|
|
118 757.21
|
625.00
|
|
|
2.88
|
2.7101
|
2.88
|
2.80
|
|
|
7 086.92
|
43.00
|
Neuraxis, Inc. operates as a medical technology company. The Company focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. Neuraxis serves customers worldwide.